These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15885823)

  • 41. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis.
    Basáñez MG; Pion SD; Boakes E; Filipe JA; Churcher TS; Boussinesq M
    Lancet Infect Dis; 2008 May; 8(5):310-22. PubMed ID: 18471776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles.
    Blackhall WJ; Prichard RK; Beech RN
    Vet Parasitol; 2008 Mar; 152(1-2):101-7. PubMed ID: 18241994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.
    Osei-Atweneboana MY; Awadzi K; Attah SK; Boakye DA; Gyapong JO; Prichard RK
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e998. PubMed ID: 21468315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
    Duke BO
    Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Onchocerciasis control: biological research is still needed.
    Boussinesq M
    Parasite; 2008 Sep; 15(3):510-4. PubMed ID: 18814732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus.
    Huang YJ; Prichard RK
    Mol Biochem Parasitol; 1999 Aug; 102(2):273-81. PubMed ID: 10498183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.
    Mwetta E; Hills E
    East Afr Med J; 1994 Dec; 71(12):790-1. PubMed ID: 7705249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
    Nana-Djeunga HC; Bourguinat C; Pion SD; Bopda J; Kengne-Ouafo JA; Njiokou F; Prichard RK; Wanji S; Kamgno J; Boussinesq M
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2824. PubMed ID: 24762816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.
    Hoerauf A; Specht S; Büttner M; Pfarr K; Mand S; Fimmers R; Marfo-Debrekyei Y; Konadu P; Debrah AY; Bandi C; Brattig N; Albers A; Larbi J; Batsa L; Taylor MJ; Adjei O; Büttner DW
    Med Microbiol Immunol; 2008 Sep; 197(3):295-311. PubMed ID: 17999080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cloning and characterization of cDNAs encoding beta-tubulin from Dirofilaria immitis and Onchocerca volvulus.
    Geary TG; Nulf SC; Alexander-Bowman SJ; Mahmoud BM; Prichard RK; Klein RD
    J Parasitol; 1998 Apr; 84(2):356-60. PubMed ID: 9576511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of antibodies to onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin.
    Gómez-Priego A; Mendoza R; de-la-Rosa JL
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):40-3. PubMed ID: 15642982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment.
    Duke BO; Marty AM; Peett DL; Gardo J; Pion SD; Kamgno J; Boussinesq M
    Parasitology; 2002 Nov; 125(Pt 5):431-44. PubMed ID: 12458827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What is the real target for ivermectin resistance selection in Onchocerca volvulus?
    Grant W
    Parasitol Today; 2000 Nov; 16(11):458-9; discussion 501-2. PubMed ID: 11063850
    [No Abstract]   [Full Text] [Related]  

  • 55. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
    Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
    Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Research notes from the Onchocerciasis Chemotherapy Research Centre, Ghana.
    Awadzi K
    Ann Trop Med Parasitol; 1997 Oct; 91(7):703-11. PubMed ID: 9625924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
    Mackenzie CD; Geary TG
    Expert Rev Anti Infect Ther; 2011 May; 9(5):497-501. PubMed ID: 21609260
    [No Abstract]   [Full Text] [Related]  

  • 58. The mitochondrial heat shock protein 60 (HSP60) is up-regulated in Onchocerca volvulus after the depletion of Wolbachia.
    Pfarr KM; Heider U; Schmetz C; Büttner DW; Hoerauf A
    Parasitology; 2008 Apr; 135(4):529-38. PubMed ID: 18205985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin.
    Kläger SL; Whitworth JA; Downham MD
    Trop Med Int Health; 1996 Oct; 1(5):581-9. PubMed ID: 8911442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
    Adewale B; Oyerinde JP; Mafe MA
    West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.